
Strykr Analysis
BearishStrykr Pulse 38/100. The market’s eerie calm is masking real risks. Positioning is stretched, and volatility is coiled. Threat Level 4/5.
If you’re looking for action, the Nasdaq is the last place you’d expect to find it today. The index is frozen at 22,535.074, unchanged, as if someone hit pause on the tape. But don’t let the stillness fool you. Under the surface, the market is quietly bracing for a volatility spike that could make the last few weeks look like a warm-up act. The VIX is parked at $22.18, flat as a pancake, but that’s a mirage. The real story is the eerie calm in tech while the rest of the world is lighting matches around oil barrels.
Let’s rewind. In the past 24 hours, headlines have been a parade of geopolitical anxiety: reciprocal strikes between Iran and its neighbors, data centers getting hit, and oil futures swinging like a caffeinated day trader. Yet the Nasdaq hasn’t budged. No panic, no euphoria. Just a collective market shrug. Some will say this is resilience. I say it’s the calm before the storm.
Why? Because this is not how risk works. When the world is on edge, tech is supposed to move. Instead, we’re getting a market that’s eerily quiet, like the moments before a flash crash. The S&P 500 is also stuck at 6,748.17, barely a ripple. But the backdrop is anything but stable. Oil is flirting with $94, and the S&P’s dividend outlook is dimming. There’s a whiff of stagflation in the air, and the algos are pretending not to notice.
Let’s talk context. The last time the VIX sat above $20 for this long with the Nasdaq refusing to budge, we were in the late innings of the 2022 bear market. Back then, the market’s complacency was shattered by a sudden spike in volatility that wiped out weeks of gains in hours. Today, the setup is even more precarious. Tech valuations are richer, macro risks are higher, and the Fed is still lurking with rate hike threats. The market is pricing in perfection, but the world is anything but perfect.
Cross-asset correlations are breaking down. Normally, you’d expect tech to trade inversely to oil, but that relationship has decoupled. Energy prices are up, but tech is flat. Safe havens like gold are catching a bid, but the Nasdaq is in a holding pattern. This is not normal. It’s a sign that positioning is stretched and liquidity is thin. The next move could be violent.
The news flow is relentless. Iran’s attacks on data centers “shook the market to the core,” according to Tanto Capital’s Ozan Özkural. Yet the Nasdaq yawned. Dividend futures for the S&P 500 are signaling lower payouts, a classic warning sign for risk assets. Financials are flashing momentum warnings, and yet, tech is the eye of the storm. This is not a bullish setup. It’s a market begging for a catalyst.
What’s the catalyst? The economic calendar is loaded for early April: ISM Services PMI, Non-Farm Payrolls, Unemployment Rate. These are not just routine data drops. They’re potential landmines. If the jobs data disappoints, the narrative of a soft landing evaporates. If inflation surprises to the upside, the Fed gets hawkish, and tech gets smoked.
Strykr Watch
Here’s what matters now: 22,500 is the line in the sand for the Nasdaq. If we break below that, the next support is a long way down at 21,900. Resistance is tight at 22,750, but don’t expect a clean breakout. The VIX holding above $22 is a red flag. RSI on the Nasdaq is stuck near 54, neither overbought nor oversold, but momentum is waning. The 50-day moving average is creeping up, but price action is stalling. This is not the time to get complacent.
On the S&P 500, 6,700 is critical. A break below opens the door to a fast move lower. Watch for volume spikes, if liquidity dries up, the next move will be sharp. Options skew is starting to tilt bearish, with put premiums rising. This is classic pre-volatility positioning.
The risk here is not just downside. It’s a sudden, outsized move in either direction. The market is coiled, and the spring is loaded. Don’t get caught leaning the wrong way.
What could go wrong? Plenty. If the Middle East situation escalates, energy prices could spike, dragging equities lower. If the Fed signals more rate hikes, tech will be the first to get hit. If dividend cuts accelerate, income investors will rotate out of risk assets. And if liquidity evaporates, we could see a flash crash reminiscent of 2020. The market is not prepared for a left-tail event.
But there’s opportunity here, too. If you’re nimble, this is the time to fade extremes. Long volatility trades, buying calls on the VIX or puts on the Nasdaq, look attractive. If the Nasdaq dips to 22,000, that’s a buy zone for a tactical bounce, but keep stops tight. If we break above 22,750, momentum chasers will pile in, but don’t overstay your welcome. The risk-reward is asymmetric.
Strykr Take
This is not a market for tourists. The calm in tech is a trap, not a signal to pile in. Position for volatility, not for trend. When the move comes, it will be fast and brutal. Stay nimble, keep your stops tight, and don’t fall asleep at the wheel. The Nasdaq’s stillness is the biggest tell of all. The next move will be anything but boring.
Sources (5)
Dow Jones futures shift into green as Iran reciprocal strikes continue
US futures pushed into positive territory on Tuesday as headlines from the Middle East continued to prop up energy prices, while the Federal Reserve b
I Have 2 Specific Lines In The Sand
The S&P 500 remains inversely correlated with WTI crude, which fell below $94 as geopolitical tensions eased slightly. Iran's control of the Strait of
Top 3 Financial Stocks That May Keep You Up At Night This Quarter
As of March 17, 2026, three stocks in the financial sector could be flashing a real warning to investors who value momentum as a key criteria in their
The Outlook For S&P 500 Dividends In March 2026
The outlook for the S&P 500's dividends dimmed since previous snapshot of their future. Dividend futures indicate the amount of dividends per share to
Biotechs Breathe Easy As Vinay Prasad Plans His Exit. But Should They?
The FDA's embattled vaccine chief, Vinay Prasad, will exit the agency. But that doesn't mean biotech stocks should breathe easy.
